Painless, Non-Invasive Skin Cancer TherapyLearn More
Bringing back Quality of Life
Need an Appointment?
Has COVID-19 changed or postponed your Skin Cancer treatment date?
With the Rhenium-SCT Referral Program we connect you with the nearest treatment center.
Rhenium-SCT Referral Program:
request the next possible treatment date here.
Production of high-energy beta emitting 188Re
Various sizes available
up to 150GBq (4Ci) 188W
High activity concentration
up to 9GBq/ml
Variable elution volume
Elution volume of 5-14 ml (partial elution for small volumes)
188W < 0.01 % in relation to 188Re at calibration time
B.J. Madan & Co India and OncoBeta announce exclusive distribution agreement for W/Re-188 generators.
By darksy / March 6, 2020
New Delhi, India and Garching near Munich, Germany, 6th March, 2020. B.J Madan & Co and OncoBeta announced the execution...Read More
RadioMedix and OncoBeta announce exclusive distribution agreement for W/Re-188 generators in U.S. and Canada.
By darksy / February 7, 2020
RadioMedix and OncoBeta today announced the execution of an exclusive distribution agreement for the next generation of W/Re-188 generators in the U.S. and Canada.Read More
By darksy / December 23, 2019
OncoBeta- A Pioneer And Innovator In The Epidermal Radioisotope Therapy Sector Skin is the largest organ of the body and...Read More
By darksy / December 10, 2019
OncoBeta recognized as the Most Compassionate Skin Cancer Therapy Provider in 2019. OncoBeta®, a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), has recently been presented with the CV Magazine’s Corporate Excellence Award for the Most Compassionate Skin Cancer Therapy Provider in 2019.Read More
By darksy / October 4, 2019
The first Rhenium-SCT® treatment was accomplished by the interregional professional association for nuclear medicine in Hanau Dr. Lutz-Hendrik Holle, Medical Director of the interregional professional association for nuclear medicine in Hanau, has accomplished the first Rhenium-SCT® (Skin Cancer Therapy) treatment in Germany.Read More
By darksy / July 5, 2019
New recognition of OncoBeta’s success in developing and providing an innovative therapy for non-melanoma skin cancer patients. July 5, 2019;...Read More
By darksy / May 23, 2019
May 13 2019, Garching n. Munich, Germany– OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope...Read More
By darksy / April 5, 2019
Recognition for OncoBeta`s mission to give non-melanocytic skin cancer patients back their quality of life. April 05, 2019; Garching near...Read More
By darksy / February 20, 2019
Recognition of OncoBeta’s success in developing and providing an innovative therapy for patients suffering from non-melanocytic skin cancer Feb 20,...Read More